Newsblaster Archived Run
Click here to return to today's news.
Sunday, July 20, 2008
Articles from 07/17/2008 to 07/20/2008
Last update: 4:22 AM EST
Search for:
U.S.
World
Finance
Sci/Tech
Entertainment
Sports

View Today's Images

Back to Archive Index

About Newsblaster

About today's run

Newsblaster in Press

Academic Papers

Article Sources:
washingtonpost.com
(186 articles)
nytimes.com
(148 articles)
seattletimes.
nwsource.com

(146 articles)
news.bbc.co.uk
(107 articles)
cbc.ca
(81 articles)
baltimoresun.com
(58 articles)
latimes.com
(49 articles)
foxnews.com
(46 articles)
boston.com
(40 articles)
nypost.com
(39 articles)
ft.com
(32 articles)
abcnews.go.com
(28 articles)
suntimes.com
(26 articles)
dallasnews.com
(18 articles)
haaretz.com
(18 articles)
timesonline.co.uk
(18 articles)
cnn.com
(17 articles)
technology.
timesonline.co.uk

(8 articles)
entertainment.
timesonline.co.uk

(7 articles)
sfgate.com
(5 articles)
msnbc.msn.com
(5 articles)
cbsnews.com
(4 articles)
topics.latimes.com
(2 articles)
nature.com
(2 articles)
latimesblogs.
latimes.com

(2 articles)








Science/Technology
Alzheimer's vaccine stopped plaque, not dementia (Science/Technology, 4 articles)
Doctors are becoming more skilled at diagnosing Alzheimer's disease and other forms of dementia, but health care experts say there is still vast room for improvement, especially in catching the insidious, mind-robbing diseases before the most disabling symptoms set in. With that in mind, Bay Area medical centers have been developing a variety of diagnostic programs for patients and caregivers - from special memory and aging centers to classes that discuss the difference between simple memory loss and dementia. At UCSF, geriatric specialists last month introduced plans to use Internet staples like YouTube and Facebook to help people recognize the earliest signs of dementia. A pill once used as an antihistamine in Russia has shown a slight but unique promise for treating Alzheimer's disease and is now on a fast track to drug studies in the United States. In another first, Dimebon's effect continued for more than a year, while current Alzheimer's treatments are known to peak at three or six months and then begin to lose their effects. LONDON - Some doctors have long suspected that if the plaque that builds up in the brains of patients with Alzheimer's disease could be removed, they could be saved.






blaster@cs.columbia.edu